EZH2 and cancer: We ruled out a central role for EZH2 methyltransferase activity in the refractoriness to SAHA in these cells, although the dependency on a non-catalytic role for EZH2 cannot be completely discounted, as it is known to affect the survival of the SWI/SNF-mutant cancer cells14.